Case-based polymedication challenges

Size: px
Start display at page:

Download "Case-based polymedication challenges"

Transcription

1 Case-based plymedicatin challenges Luise Mallet, B.Sc.Pharm., Pharm.D., BCGP, FESCP Prfesseure titulaire de clinique Faculty f Pharmacie, Université de Mntréal Clinical Pharmacist in Geriatrics McGill University Health Center 1

2 Cnflit f interest N cnflict f interest t declare 2

3 Objectives At the end f the presentatin, participants will be able t: Knw sme strategies fr apprpriate prescribing in frail elderly in rder t avid geriatric syndrmes; Knw hw t discntinue medicatins safely (deprescribing) in lder patients using case-based plymedicatin. 3

4 «When an elderly patient presents with a status change, unless prven therwise, it shuld be assumed t be a medicatin related prblem». Jerry Gurwitz,M.D. 4

5 Prblems with drugs in the elderly Evidence-based medecine Time t benefit Life expectancy Adherence t treatment Pharmackinetic changes Pharmacdynamic changes Reduced hmestatic functin Beers criteria STOPP and START Antichlinergic lad Geriatric syndrme Multiple diseases, medicatins Drug interactins Medicatin cascade Medicatins and Functinal/cgnitive status Adverse drug events 5

6 Geriatric syndrmes «Les grands géants» Delirium Falls Urinary incntinence Malnutritin, weight lss Pain Plypharmacy 6

7 Geriatric syndrmes Falls Delirium Anrexia, malnutritin Urinary incntinence Functinal decline Plypharmacy Medicatins > 4 drugs, antipsychtiques, antidépresseurs, benzdiazépines, etc Antichlinergic medicatins Digxin, metrnidazle, enalapril, lithium Diuretics, ACEI, ACHe inhibitrs, sedativehypntics Antipsychtics, antihypertensives, etc etc Mre than 5 medicatins 7

8 Mr. Falls 79 year ld man 3rd visit t ER fr recurrent falls. Lives with his daughter. Medical histry: Diabetes Neurpathy, retinpathy Hypertensin NKDA Weight: 70 kg Height: 1,67 m Cr = 79 uml/l (stable) ClCr = 60 ml/min 8

9 M. Falls Met with the patient fr his medicatin histry Many falls in past mnths Back pain fllwing his falls Medicatins prescribed by 6 different physicians 9

10 Medicatins: M. Falls Metfrmin 50 mg + Sitagliptin 50 mg 2 x/day Gliclazide MR 60 mg 1 x/day Canagliflzin 100 mg 1 x/day Insuline Lantus 30 u sc at bedtime Simvastatin 20 mg 1 x/day Irbesartan 75 mg 1 x/day Tamsulsin 0.4 mg 1 x/day ECASA 80 mg 1 x/day Lax-a-day 17 g daily in mrning Clace 200 mg daily at bedtime Hydrmrphne 0.5 mg p q 4 hrs prn Acetaminphen 500 mg 1-2 tab q 4-6 hr Vltaren emulgel apply 4 times daily prn 10

11 Hw d we begin Dyks D. Apprch t medicatin reviews in lder adults p. Chapter in Medicatin-related falls in lder persn. Springer

12 12

13 Match medical prblems and medicatins Medical prblems Falls 3rd visit at ER Diabetes Hypertensin Chlesterl Medicatins Metfrmin 50 mg + Sitagliptin 50 mg 2 x/day Gliclazide MR 60 mg 1 x/day Canagliflzin 100 mg 1 x/day Insuline Lantus 30 u sc at bedtime Irbesartan 75 mg 1 x/day Tamsulsin 0.4 mg 1 x/day Metfrmin 50 mg + Sitagliptin 50 mg 2 x/day Gliclazide MR 60 mg 1 x/day Canagliflzin 100 mg 1 x/day Insuline Lantus 30 u sc at bedtime Irbesartan 75 mg 1 x/day/ Simvastastin 20 mg 1x/day?? Tamsulsin 0.4 mg 1 x/day 13

14 Match medical prblems and medicatins Medical prblems Pain Cnstipatin Medicatins Hydrmrphne 0.5 mg p q 4 hrs prn Acetaminphen 500 mg 1-2 tab q 4-6 hr Vltaren emulgel Lax-a-day 17 g daily in mrning Clace 200 mg daily at bedtime 14

15 Medicatins: M. Falls/Chrnlgy Metfrmin 50 mg + Sitagliptin 50 mg 2 x/day Gliclazide MR 60 mg 1 x/day Canagliflzin 100 mg 1 x/day (End f Dec 2015) Insuline Lantus 30 u sc at bedtime Simvastatin 20 mg 1 x/day Irbesartan 75 mg 1 x/day Tamsulsin 0.4 mg 1 x/day (Mars 2016) ECASA 80 mg une 1 x/day Hydrmrphne 0.5 mg p q 4 hrs prn (April 2016) Acetaminphen 500 mg 1-2 tab q 4-6 hr Vltaren emulgel apply 4 times daily prn Lax-a-day 17 g 1 x/day Clace 200 mg p 1 x/day at bedtime 15

16 M. Falls Chrnlgy Canagliflzin 100 daily (End December 2015) Tamsulsin 0.4 mg daily (March 2016) Clavulin 875/125 bid x 10 days (March 2016 ) Patient mentins an assciatin between his new prescriptins fr canagliflzin, tamsulsin and his falls Then tw ER visits: (April 2016) Acetaminphen 500 mg 1-2 tab q 4-6 hr (1 st visit) Dilaudid 0.5 mg p q 4 hrs au prn (2 nd visit) Clace 200 mg at bedtime Lax-a-day 17 g une fis par jur Vltaren emulgel 16

17 What is yur evaluatin? 17

18 Medicatins: M. Falls/Chrnlgy Metfrmin 50 mg + Sitagliptin 50 mg 2 x/day Gliclazide MR 60 mg 1 x/day Canagliflzin 100 mg 1 x/day (End f Dec 2015) Insuline Lantus 30 u sc at bedtime Simvastatin 20 mg 1 x/day Irbesartan 75 mg 1 x/day Tamsulsin 0.4 mg 1 x/day (Mars 2016) ECASA 80 mg une 1 x/day Hydrmrphne 0.5 mg p q 4 hrs prn (April 2016) Acetaminphen 500 mg 1-2 tab q 4-6 hr Vltaren emulgel apply 4 times daily prn Lax-a-day 17 g 1 x/day Clace 200 mg p 1 x/day at bedtime 18

19 Prescibing cascademédeicamenteuse Prescriptin f drug n 0 1 Þ Side effect misinterpreted as a new medical prblem Þ Prescriptin f drug n 0 2 Þ Side effect misinterpreted as a new medical prblem Þ and the cascade cntinue Rchn P, et cll. BMJ 1997;315: Annual Refresher Curse McGill 19

20 Chrnlgy f events Drug 1 Side effects Drug 2 Side effects 20

21 Side effects 21

22 Medicatins: M. Falls: yur evaluatin Metfrmin 50 mg + Sitagliptin 50 mg 2 x/day Gliclazide MR 60 mg 1 x/day Canagliflzin 100 mg 1 x/day Insuline Lantus 30 u sc at bedtime Why 4 drugs fr his DM? Simvastatin 20 mg 1 x/day Irbesartan 75 mg 1 x/day Tamsulsin 0.4 mg 1 x/day ECASA 80 mg 1 x/day Lax-a-day 17 g daily in mrning Clace 200 mg daily at bedtime Hydrmrphne 0.5 mg p q 4 hrs prn Acetaminphen 500 mg 1-2 tab q 4-6 hr Vltaren emulgel apply 4 times daily prn 22

23 Fall as a geriatric syndrme Hypglycemia Orthstatic hyptensin Fall Acute Illness Medicatins Neurpathy Annual Refresher Curse McGill 23

24 Amldipine Fursemide Oxybutynin Dnepezil 24

25 Lecuteur D et al. Deprescribing. Australian Prescriber 2011;34:

26 Sctt IA, et al. JAMA 2015:175:

27 Annual Refresher Curse McGill 27

28 90 year-ld wman wh lives with her sn Was asked t review her medicatins He is respnsable t manage the medicatins, ck meals, etc. CLSC every mnth. Medical prblems: Diabetes, hypertensin, steprsis, dementia, CKD Weight: 60 kg Height: 152 cm Créatinine: 165 uml/l Calclated Cl Cr = 15 ml/min Mrs. N 28

29 Medicatins Medicatins: Amldipine 2.5 mg daily Candesartan 16 mg daily Indapamide 2,5 mg daily Omeprazle 20 mg daily Alendrnate 70 mg p every sunday Dmeperidne 10 mg twice daily Metfrmin 850 mg twice daily Saxagliptin 5 mg daily Calcium Vitamin D 400 U bid Atrvastatin 20 mg daily Acetaminphen 500 mg p 3 fis daily prn 29

30 Geriatric principles Des she take her medicatins? Difficult t cmmunicate with the patient Meeting with the sn: respnsible t give the medicatins Says that his mther takes t many medicatins Des nt give meprazle, dmperidne, atrvastatin and acetaminphen 30

31 31

32 Medicatins Medicatins: Amldipine 2.5 mg daily Candesartan 16 mg daily Indapamide 2,5 mg daily Omeprazle 20 mg daily Alendrnate 70 mg p every sunday Dmeperidne 10 mg twice daily Metfrmin 850 mg twice daily Saxagliptin 5 mg daily Calcium Vitamin D 400 U bid Atrvastatin 20 mg daily Acetaminphen 500 mg p 3 fis daily prn 32

33 Medicatins Medicatins: Amldipine 2.5 mg daily Candesartan 16 mg daily Indapamide 2,5 mg daily Alendrnate 70 mg p every Sunday Metfrmin 850 mg twice daily Saxagliptin 5 mg daily Calcium Vitamin D 400 U bid Calculated ClCr : 15 ml/min At hme: glucse level: 9 t 12 mml/l (accrding t his sn) HbA1 C 6,5% (frm DSQ past 2 mnths) 33

34 Match medical prblems and medicatins Medical prblems Diabetes Drugs Metfrmin 850 mg bid Saxagliptin 5 mg daily Therapeutic bjectives HbA1 C <8.5% Glucse: 9 t 12 mml/l Others Metfrmin nt indicated if CrCl <30 ml/min Saxagliptin: CrCl 50 ml/min: 2.5 mg nce daily Osteprse Alendrnate 70 mg p every Sunday Calcium Vit D 400 U bid N fracture Has been taking it fr at least 10 years accrding t her sn Alendrnate: nt indicated if CrCl < 35 ml/min Vitamin D 10,000 u q week Calcium 500 mg daily 34

35 Questin Is this patient fit, vulnerable r frail? 1. Fit 2. Vulnerable 3. Frail 35

36 Definitin f an elderly persn âgée Independent elderly persn, withut c-mrbidity, verall gd health status; (Bnne santé/fit) Partially dependent elderly persn with 1 t 2 c-mrditities; (Vulnérable/vulnerable) Elderly persn with functinal r cgnitive limitatin with many c-mrbidities, presenting with at least ne geriatric syndrme; (Fragile/frail) 36

37 Questin Is this patient fit, vulnerable r frail? 1. Fit 2. Vulnerable 3. Frail 37

38 Questin Which is yur therapeutic bjective fr this 91 year ld patient with hypertensin? 1. < 120 mm Hg systlic BP (as per SPRINT) 2. < 160 mm Hg systlic BP 3. < 150 mm Hg systlic BP(as per HYVET study) age f the patient 38

39 Questin Which is yur therapeutic bjective fr this 91 year ld patient with hypertensin? 1. < 120 mm Hg systlic BP (as per SPRINT) 2. < 160 mm Hg systlic BP withut rthstatic hyptensin 3. < 150 mm Hg systlic BP withut rthstatic hyptensin (as per HYVET study) age f the patient 39

40 Match medical prblems and medicatins Medical prblems Drugs Therapeutic bjectives Others Hypertensin Amldipine 2.5 mg daily Candesartan 16 mg daily Indapamide 2.5 mg daily Bld pressure: <160 mmhg withut rthstatic hyptensin Indapamide: Canadian labeling cntraindicates use in severe impairment (CrCl <30 ml/minute) Candersartan: in patients with severe renal impairment (CrCl <30 ml/minute/1.73 m 2 ) AUC and C max were apprximately dubled after repeated dsing. Amldipine: can increase dse if needed 40

41 Medicatins Medicatins: Amldipine 5 mg daily Saxagliptin 2,5 mg daily Calcium 500 mg daily Vitamin D 10, u p q week 41

42 91 year ld wman admitted fr «failure t thrive». Acute renal insufficency n CKD Creatinine: 189 uml/l Medicaments : Amldipine 5 mg p daily Candesartan 16 mg p daily Indapamide 2.5 mg p daily Pantprazle 40 mg une fis par jur Metfrmin 1 gm + Saxagliptin 2,5 mg twice daily Vitamine D 10,000 un q week Calcium 500 mg daily Lactate: 4,0 (0,6-2,4) 11 mnths later 42

43 Apprpriate prescribing: The Pyramid Mdel Ref: Hlmes, Arch Int Med,

44 79 year-ld wman admitted t ER fr Gen Det Medicatins at hme: Pregabaline 75 mg p 2x/d Venlafaxine XR 75 mg p daily Dmperidne 10 mg p qid Metclpramide 10 mg p bid Clnazepam 0.5 mg p qid Risperidne 0.5 mg p daily Dimenhydrinate 50 mg p q 4 hrs prn (180/mnth) Cumadin 5 mg p daily Janumet mg (metfrmine + sitagliptine) bid Glyburide 5 mg p bid Rsuvastatin 20 mg p daily Ramipril 5 mg p daily Bisprll 5 mg p daily Amldipine 10 mg p daily Pantprazle 40 mg p daily Levthyrxine mg p daily Clace 100 mg p Annual bid Refresher Curse McGill

45 79 year-ld wman admitted t ER fr Gen Det Pregabaline 75 mg p 2x/d Venlafaxine XR 75 mg p daily: was n Citalpram 40 mg p daily d/c april Dmperidne 10 mg p qid Metclpramide 10 mg p bid: EPS Clnazepam 0.5 mg p qid: Benzdiazepine lng t 1/2 Risperidne 0.5 mg p dialy Dimenhydrinate 50 mg p q 4 hrs prn: antichlinergic Cumadin 5 mg p daily Janumet mg (metfrmine + sitagliptine) bid Glyburide 5 mg p bid: Accumulatin lng t 1/2 and active metablite Rsuvastatin 20 mg p daily Ramipril 5 mg p daily Bisprll 5 mg p daily Amldipine 10 mg p daily Pantprazle 40 mg p daily Levthyrxine mg p daily?? Hw des she take her meds Clace 100 mg p bid 45

46 Thank Yu and Healthy Aging

Significance of Chronic Kidney Disease in 2015

Significance of Chronic Kidney Disease in 2015 1 Significance f Chrnic Kidney Disease in 2015 There is still a requirement within QOF t keep a register f peple with CKD stages 3-5. The ther CKD QOF targets have been retired. This is because CKD care

More information

Adjusting and Withdrawing Medications in the Elderly

Adjusting and Withdrawing Medications in the Elderly Adjusting and Withdrawing Medications in the Elderly Louise Mallet, B.Sc.Pharm., Pharm.D., CGP Professor in Clinical Pharmacy, Faculty of Pharmacy, University of Montreal Clinical Pharmacist in Geriatrics,

More information

Annex III. Amendments to relevant sections of the Product Information

Annex III. Amendments to relevant sections of the Product Information Changes t the Prduct infrmatin as apprved by the CHMP n 13 Octber 2016, pending endrsement by the Eurpean Cmmissin Annex III Amendments t relevant sectins f the Prduct Infrmatin Nte: These amendments t

More information

Medications. o Aspirin 100mg daily Risedronate 35mg weekly. o Clopidogrel 75mg daily Calcium/VitD 600mg/1000U

Medications. o Aspirin 100mg daily Risedronate 35mg weekly. o Clopidogrel 75mg daily Calcium/VitD 600mg/1000U Medicatins Aspirin 100mg daily Risedrnate 35mg weekly Clpidgrel 75mg daily Calcium/VitD 600mg/1000U Atrvastatin 80mg ncte Allpurinl 100mg daily Diltiazem CD 240mg daily Laxatives daily Frusemide 80mg BD

More information

Polypharmacy in Geriatrics Home for the Summer Notre-Dame de Lourdes. Janine Grenier

Polypharmacy in Geriatrics Home for the Summer Notre-Dame de Lourdes. Janine Grenier Plypharmacy in Geriatrics Hme fr the Summer Ntre-Dame de Lurdes Janine Grenier 2016 Plypharmacy in the geriatric ppulatin is becming a cmmn cncern, with many patients being prescribed multiple medicatins

More information

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745

SUMMACARE COMMERCIAL MEDICATION REQUEST GUIDELINES. ANTI-OBESITY AGENTS Generic Brand HICL GCN Exception/Other QSYMIA 32515, 32744, 32746, 32745 Generic Brand HICL GCN Exceptin/Other NALTREXONE CONTRAVE ER 41389 /BUPROPION LORCASERIN BELVIQ 34733 PHENTERMINE PHENTERMINE 20691 20692 20693 20713 PHENTERMINE LOMAIRA 20715 PHENTERMINE/TO PIRAMATE GUIDELINES

More information

Structural renal tract disease, renal calculi, or benign prostatic hypertrophy.

Structural renal tract disease, renal calculi, or benign prostatic hypertrophy. Chrnic kidney disease - nt diabetic - Management Scenari: Testing fr chrnic kidney disease Definitin Chrnic kidney disease is said t be present when there is persistent impairment f kidney functin, r evidence

More information

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS

CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS CONSENT FORM - TESTOSTERONE FOR TRANSGENDER CLIENTS Yu want t take teststerne t masculinize yur bdy. Befre taking it, there are several things yu need t knw abut. They are the pssible advantages, disadvantages,

More information

You may have a higher risk of bleeding if you take warfarin sodium tablets and:

You may have a higher risk of bleeding if you take warfarin sodium tablets and: MEDICATION GUIDE Warfarin (WAR-far-in) Sdium (SO-dee-um) Tablets USP The 7.5 mg tablets cntain FD&C Yellw N. 5 (tartrazine), which may cause allergic-type reactins (including brnchial asthma) in certain

More information

Opioid Analgesics PA Request Provider Checklist

Opioid Analgesics PA Request Provider Checklist WVP Health Authrity Updated 05-12-2015 Opiid Analgesics PA Request Prvider Checklist *** If pssible, please include the fllwing infrmatin with PA requests fr piid analgesics. Including the requested infrmatin

More information

BP Thresholds for Medical Review

BP Thresholds for Medical Review BP Threshlds fr Medical Review Wmen presents t GP pstnatally with high bld pressure r referred t GP by midwife GP t review patient n the same day if BP>150/100. If BP (dne by midwife) persistently 140-149/90-99,

More information

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only.

The clinical trial information provided in this public disclosure synopsis is supplied for informational purposes only. The clinical trial infrmatin prvided in this public disclsure synpsis is supplied fr infrmatinal purpses nly. Please nte that the results reprted in any single trial may nt reflect the verall ptential

More information

MEDICATION GUIDE. (canagliflozin) Tablets

MEDICATION GUIDE. (canagliflozin) Tablets MEDICATION GUIDE INVOKANA (in-v-kahn-uh) (canagliflzin) Tablets What is the mst imprtant infrmatin I shuld knw abut INVOKANA? INVOKANA can cause imprtant side effects, including: Dehydratin. INVOKANA can

More information

Obesity/Morbid Obesity/BMI

Obesity/Morbid Obesity/BMI Obesity/mrbid besity/bdy mass index (adult) Obesity/Mrbid Obesity/BMI Definitins and backgrund Diagnsis cde assignment is based n the prvider s clinical judgment and crrespnding medical recrd dcumentatin

More information

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review:

Bedfordshire and Hertfordshire DRAFT Priorities forum statement Number: Subject: Prostatism Date of decision: January 2010 Date of review: Bedfrdshire and Hertfrdshire DRAFT Pririties frum statement Number: Subject: Prstatism Date f decisin: January 2010 Date f review: Referral criteria Mst men with lwer urinary tract symptms due t benign

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment r prphylaxis. Evidence supprting this guidance is detailed belw.

More information

Osteoporosis Fast Facts

Osteoporosis Fast Facts Osteprsis Fast Facts Fast Facts n Osteprsis Definitin Osteprsis, r prus bne, is a disease characterized by lw bne mass and structural deteriratin f bne tissue, leading t bne fragility and an increased

More information

MEDICATION GUIDE. Reference ID:

MEDICATION GUIDE. Reference ID: MEDICATION GUIDE GLYXAMBI (glik-sam-bee) (empagliflzin and linagliptin) Tablets Read this Medicatin Guide carefully befre yu start taking GLYXAMBI and each time yu get a refill. There may be new infrmatin.

More information

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion

Intravenous Vancomycin Use in Adults Intermittent (Pulsed) Infusion Intravenus Vancmycin Use in Adults Intermittent (Pulsed) Infusin Backgrund This plicy cvers the use f intravenus vancmycin prescribed as an intermittent (pulsed) infusin. This can be used fr treatment

More information

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service

University College Hospital. Pump school Starting on an insulin pump. Children and Young People s Diabetes Service University Cllege Hspital Pump schl Starting n an insulin pump Children and Yung Peple s Diabetes Service 2 If yu wuld like this dcument in anther language r frmat, r require the services f an interpreter,

More information

Pain relief after surgery

Pain relief after surgery Pain relief after surgery Imprtant infrmatin fr patients www.mchft.nhs.uk We care because yu matter This leaflet is designed t help yu cntrl any pain yu may have at hme fllwing yur peratin. Please read

More information

Cognitive enhancers for the treatment of Alzheimer s disease

Cognitive enhancers for the treatment of Alzheimer s disease Cmprehensive Research Plan: Cgnitive enhancers fr the treatment f Alzheimer s disease Pharmacepidemilgy Unit February 13 th, 2015 30 Bnd Street, Trnt ON, M5B 1W8 www.dprn.ca inf@dprn.ca 2 ODPRN Drug Class

More information

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone!

Thank you for committing to engage pharmacists regarding the incredible opportunity for them to prevent opioid overdose deaths by providing naloxone! Thank yu fr cmmitting t engage pharmacists regarding the incredible pprtunity fr them t prevent piid verdse deaths by prviding nalxne! If yu encunter cmplicated questins that yu are unable t answer, please

More information

Health and Lifestyle Questionnaire

Health and Lifestyle Questionnaire Health and Lifestyle Questinnaire Name Tday s date Date f birth Clinic visit date Please tell us the reasn fr yur visit Weight histry Desired r gal weight Height Lwest adult weight When? Highest adult

More information

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to:

PATIENT INFORMATION. Rosuvastatin calcium tablets are used along with diet to: PATIENT INFORMATION Rsuvastatin Calcium (re-soo-va-stat-in KAL-see-um) Tablets Read this Patient Infrmatin carefully befre yu start taking rsuvastatin calcium tablets and each time yu get a refill. If

More information

Part 1 describes the reasoning and recommendations up to node 2 of the algorithm.

Part 1 describes the reasoning and recommendations up to node 2 of the algorithm. Presented by: David Osser, MD Assciate Prfessr f Psychiatry Harvard Medical Schl Dr. Osser has n cnflicts f interest t disclse. This dcument is a summary f selected clinical pearls frm Dr. Osser s presentatin:

More information

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP)

My Symptoms and Medical History for Adult Chronic Immune Thrombocytopenia (ITP) My Symptms and Medical Histry fr Adult Chrnic Immune Thrmbcytpenia (ITP) Call t talk t a registered nurse 1-855-7Nplate (1-855-767-5283), Mnday Friday, 9:00 AM 9:00 PM ET Indicatin Nplate is a man-made

More information

SECTION O. MEDICATIONS

SECTION O. MEDICATIONS SECTION O. MEDICATIONS 1. NUMBER OF MEDICA TIONS (Recrd the number f different medicatins used in the last 7 days; enter "0" if nne used) O1. Number f Medicatins (7-day lk back) Intent: Prcess: Cding:

More information

Depression in the Older Adults. Summary

Depression in the Older Adults. Summary Depressin in the Older Adults Summary Majr depressive disrder (MDD) is the leading cause f disability accrding t the Wrld Health Organizatin. Cmmn clinical cnditins and previus research has shwn that the

More information

PART III: CONSUMER INFORMATION

PART III: CONSUMER INFORMATION IMPORTANT: PLEASE READ PART III: CONSUMER INFORMATION Pr ZERIT Stavudine This leaflet is Part III f a three-part Prduct Mngaph published when ZERIT was apprved fr sale in Canada and is designed specifically

More information

Essentials of Blood Pressure Management Session 5: Blood Pressure, Kidneys and Complications

Essentials of Blood Pressure Management Session 5: Blood Pressure, Kidneys and Complications Kidney and HTN: Tw Beans in a Pd will begin at 12:00 PM ET Dwnlad sessin materials and view archived sessins at http://bit.ly/ufbpwebpage Add Flavr and Imprve Nutritin with Fresh Herbs Thursday, July 12

More information

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV

MEDICATION GUIDE QSYMIA (Kyoo sim ee uh) (phentermine and topiramate extended-release) Capsules CIV MEDICATION GUIDE QSYMIA (Ky sim ee uh) (phentermine and tpiramate extended-release) Capsules CIV Read this Medicatin Guide befre yu start taking Qsymia and each time yu get a refill. There may be new infrmatin.

More information

/0515 Medication Guide Aripiprazole Tablets

/0515 Medication Guide Aripiprazole Tablets 8415721/0515 Medicatin Guide Aripiprazle Tablets (air-eh-pip-rah-zle) Read this Medicatin Guide befre yu start taking aripiprazle tablets and each time yu get a refill. There may be new infrmatin. This

More information

Swindon Joint Strategic Needs Assessment Bulletin

Swindon Joint Strategic Needs Assessment Bulletin Swindn Jint Strategic Needs Assessment Bulletin Swindn Diabetes 2017 Key Pints: This JSNA gives health facts abut peple with diabetes r peple wh might get diabetes in Swindn. This helps us t plan fr medical

More information

Completing the NPA online Patient Safety Incident Report form: 2016

Completing the NPA online Patient Safety Incident Report form: 2016 Cmpleting the NPA nline Patient Safety Incident Reprt frm: 2016 The infrmatin cntained within this dcument is in line with the current Data Prtectin Act (DPA) requirements. This infrmatin may be subject

More information

STOPP START Toolkit. Supporting Medication Review. STOPP: Screening Tool of Older People s Potentially Inappropriate Prescriptions

STOPP START Toolkit. Supporting Medication Review. STOPP: Screening Tool of Older People s Potentially Inappropriate Prescriptions STOPP START Tlkit Supprting Medicatin Review STOPP: Screening Tl f Older Peple s Ptentially Inapprpriate Prescriptins START: Screening Tl t Alert Dctrs t Right (i.e. apprpriate, indicated) Treatments Cntents

More information

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center

What is Asthma? A collaborative effort of Children s Hospital of Pittsburgh of UPMC and The Pennsylvania Child Welfare Resource Center A cllabrative effrt f Children s Hspital f Pittsburgh f UPMC and The Pennsylvania Child Welfare Resurce Center What is Asthma? Jennifer E. Wlfrd, DO, MPH, FAAP Children s Hspital f Pittsburgh, Divisin

More information

Access to Heme Treatment in Canada - Survey 2018

Access to Heme Treatment in Canada - Survey 2018 Access t Heme Treatment in Canada - Survey 2018 The Canadian Assciatin fr Prphyria/Assciatin Canadienne de Prphyrie (CAP/ACP) asserts that patients with acute prphyria shuld have access t Hemin treatment,

More information

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip

Patrick J McGahan, MD Orthopaedic Surgeon Specializing in Sports Medicine/Shoulder Reconstruction Surgery Instructions Hip Patrick J McGahan, MD Orthpaedic Surgen Specializing in Sprts Medicine/Shulder Recnstructin 2801 K St, Ste 330, Sacrament, CA, 95816 (p) 916-733-5049 (f) 916-733-8914 www.patrickmcgahanmd.cm Befre Surgery

More information

Cayuga Center for Healthy Living Health and Lifestyle Questionnaire. Name: Date of Birth: Today s date: Clinic visit date:

Cayuga Center for Healthy Living Health and Lifestyle Questionnaire. Name: Date of Birth: Today s date: Clinic visit date: Cayuga Center fr Healthy Living Health and Lifestyle Questinnaire Name: Date f Birth: Tday s date: Clinic visit date: Histry f weight lss/gain: Desired r gal weight: Lwest adult weight: Highest adult weight

More information

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP

MEDICATION GUIDE Pioglitazone and Metformin Hydrochloride (PYE o GLI ta zone and met FOR min HYE-droe- KLOR-ide)Tablets, USP MEDICATION GUIDE Piglitazne and Metfrmin Hydrchlride (PYE GLI ta zne and met FOR min HYE-dre- KLOR-ide)Tablets, USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride

More information

DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY

DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY YOU AND YOUR BODY DIABETES AND PANCREATIC EXOCRINE INSUFFICIENCY kk WHY IS THIS LEAFLET FOR YOU? Pancreatic excrine insufficiency (PEI) is imprtant t understand in diabetes care due t the changing functins

More information

Paediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead

Paediatric Sepsis Form. Sinéad Horgan SSWHG Sepsis Lead Paediatric Sepsis Frm Sinéad Hrgan SSWHG Sepsis Lead www.hse.ie/sepsis Definitin A life-threatening rgan dysfunctin due t a dysregulated hst respnse t infectin N cnfirmatry test Bld cultures are psitive

More information

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol.

A Phase I Study of CEP-701 in Patients with Refractory Neuroblastoma NANT (01-03) A New Approaches to Neuroblastoma Therapy (NANT) treatment protocol. SAMPLE INFORMED CONSENT A Phase I Study f CEP-701 in Patients with Refractry Neurblastma NANT (01-03) A New Appraches t Neurblastma Therapy (NANT) treatment prtcl. The wrd yu used thrughut this dcument

More information

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline)

23/11/2015. Introduction & Aims. Methods. Methods. Survey response. Patient Survey (baseline) Intrductin & Aims Drug and Alchl Cnsultatin Liaisn (AOD CL) services aim t imprve identificatin and treatment f patients with AOD mrbidity. The csts and cnsequences f targeting AOD patients presenting

More information

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation

RoActemra (tocilizumab) for Giant Cell Arteritis (GCA) subcutaneous (SC) formulation RActemra (tcilizumab) fr Giant Cell Arteritis (GCA) subcutaneus (SC) frmulatin What yu shuld knw abut RActemra This brchure prvides key infrmatin t assist in the patient s understanding f the benefits

More information

US Public Health Service Clinical Practice Guidelines for PrEP

US Public Health Service Clinical Practice Guidelines for PrEP Webcast 1.3 US Public Health Service Clinical Practice Guidelines fr PrEP P R E S ENTED BY: M A R K T H R U N, M D A S S O C I AT E P R O F E S S O R, U N I V E R S I T Y O F C O L O R A D O, D I V I S

More information

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP

MEDICATION GUIDE Pioglitazone (pie-oh-glit-ah-zohn) and Metformin (met-fore-min) Hydrochloride Tablets USP MEDICATION GUIDE Piglitazne (pie-h-glit-ah-zhn) and Metfrmin (met-fore-min) Hydrchlride Tablets USP Read this Medicatin Guide carefully befre yu start taking piglitazne and metfrmin hydrchlride tablets

More information

Advantage EAP Employee Assistance Program

Advantage EAP Employee Assistance Program Advantage EAP Emplyee Assistance Prgram July 2014 In This Issue What might we face? Symptms f SAD Seasnal changes in biplar disrder Tips fr cmbating summer truble When t seek help Tips fr helping thse

More information

Delaying Progression. Paul Drawz, MD, MHS, MS Assistant Professor of Medicine University of MN Minneapolis, MN

Delaying Progression. Paul Drawz, MD, MHS, MS Assistant Professor of Medicine University of MN Minneapolis, MN Delaying Prgressin Paul Drawz, MD, MHS, MS Assistant Prfessr f Medicine University f MN Minneaplis, MN Disclsure Paul Drawz, MD, MHS, MS has n financial relatinships with cmmercial interest(s). Learning

More information

Adult Preventive Care Guidelines

Adult Preventive Care Guidelines Adult Preventive Care Guidelines Gundersen is yur partner fr better health. We want t wrk with yu t make sure that yu and yur family are as healthy as pssible. That can be accmplished best if we wrk tgether

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): Angitensin

More information

Influenza (Flu) Fact Sheet

Influenza (Flu) Fact Sheet Influenza (Flu) Fact Sheet What is the flu? The flu is a cntagius respiratry illness caused by influenza viruses. It can cause mild t severe illness, and at times can lead t death. Sme peple, such as lder

More information

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks

Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Diabetes and the Elderly: Medication Considerations When Determining Benefits and Risks Gretchen M. Ray, PharmD, PhC, BCACP, CDE Associate Professor UNM College of Pharmacy September 7 th, 2018 DISCLOSURES

More information

<Date> <Group> <Address1> <Address2> <City> <State> <zip> RE: 2015 Blue Physician Recognition (BPR) Program. Dear <Group>:

<Date> <Group> <Address1> <Address2> <City> <State> <zip> RE: 2015 Blue Physician Recognition (BPR) Program. Dear <Group>: Three Penn Plaza East Newark, NJ 07105-2200 HriznBlue.cm RE: 2015 Blue Physician Recgnitin (BPR) Prgram Dear : Hrizn Blue Crss Blue Shield

More information

The Dizziness Handicap Inventory ( DHI )

The Dizziness Handicap Inventory ( DHI ) The Dizziness Handicap Inventry ( DHI ) P1. Des lking up increase yur prblem? Yes E2. Because f yur prblem, d yu feel frustrated? Yes F3. Because f yur prblem, d yu restrict yur travel fr business r recreatin?

More information

Commissioning Policy: South Warwickshire CCG (SWCCG)

Commissioning Policy: South Warwickshire CCG (SWCCG) Cmmissining Plicy: Suth Warwickshire CCG (SWCCG) Treatment Indicatin Criteria FreeStyle Libre Flash Cntinuus Glucse Mnitring System Type I Diabetes Prir apprval must be requested frm the Individual Funding

More information

BSUG Database User Update Document June 15 th 2015

BSUG Database User Update Document June 15 th 2015 1 Welcme t the BSUG Online Database BSUG Audit Database is an nline database tl prvided by the BSUG t gather data relating t this subspecialty fr the purpses f prviding BSUG members with statistical reprts

More information

CLINICAL PRACTICE GUIDELINE

CLINICAL PRACTICE GUIDELINE Pages: 2 f 11 V. GUIDELINE: The fllwing guidelines are cnsistent with the 2018 Standards f Medical Care in Diabetes frm the American Diabetes Assciatin (ADA). Sme specificatins fr HEDIS measures f diabetes

More information

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or

Heart Failure (HF): Angiotensin Converting Enzyme (ACE) Inhibitor or Heart Failure (HF): Angitensin Cnverting Enzyme (ACE) Inhibitr r Angitensin Receptr Blcker (ARB) Therapy fr Left Ventricular Systlic Dysfunctin (LVSD) (NQF 0081) EMeasure Name Heart Failure (HF): EMeasure

More information

Ischemic heart disease (angina/chest pain)

Ischemic heart disease (angina/chest pain) Ischemic heart disease (angina/chest pain) External resurces Stable angina: management NICE guidelines [CG126] Updated :Aug 2016 https://www.nice.rg.uk/guidance/cg126 Chest pain f recent nset [CG95] Nvember

More information

Dr. Tozzi s and Dr. Roehrig s Patient Guide to Total Hip Replacement

Dr. Tozzi s and Dr. Roehrig s Patient Guide to Total Hip Replacement Dr. Tzzi s and Dr. Rehrig s Patient Guide t Ttal Hip Replacement This guide is meant t help yu better understand yur upcming hip surgery. It is generalized infrmatin, and individual patients have unique,

More information

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII)

Medication Guide MORPHINE SULFATE (mor-pheen) Oral Solution (CII) Medicatin Guide MORPHINE SULFATE (mr-pheen) Oral Slutin (CII) IMPORTANT: Keep Mrphine Sulfate Oral Slutin in a safe place away frm children. Accidental use by a child is a medical emergency and can cause

More information

SLEEP-WAKE QUESTIONNAIRE

SLEEP-WAKE QUESTIONNAIRE Shasta Critical Care Specialists Sleep Center: (530) 232-3017, 2701 Old Eureka Way, Suite 1J, Redding, CA 96001 Office: (530) 232-3000, 2701 Old Eureka Way, Suite 1E, Redding, CA 96001 Fax: (530) 242-8545

More information

Upper Endoscopy (EGD) Prep Guide

Upper Endoscopy (EGD) Prep Guide Upper Endscpy (EGD) Prep Guide Yu have been scheduled fr an Upper Endscpy (EGD). Plan ahead t help reduce yur stress. Use these step-by-step instructins fr a successful prcedure s that yur dctr can clearly

More information

DEPRESCRIBING IN THE ELDERLY

DEPRESCRIBING IN THE ELDERLY DEPRESCRIBING IN THE ELDERLY G E R I A T R I C S R E F R E S H E R D A Y W E D N E S D A Y, A P R I L 5 TH, 2 0 1 7 V É R O N I Q U E F R E N C H M E R K L E Y, M D, C C F P ( C O E ) B R U Y È R E C O

More information

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y

Health for Life Chiropractic At Cloverdale Mall Unit # The East Mall Etobicoke, ON, M9B 3Y Health fr Life Chirpractic At Clverdale Mall Unit #143-250 The East Mall Etbicke, ON, M9B 3Y8 416-232-1822 416-232-0060 Child and Adlescent Health Questinnaire Name:_ Birth date: Address:_ Telephne: Medical

More information

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets

MEDICATION GUIDE XARELTO (zah-rel-toe) (rivaroxaban) tablets MEDICATION GUIDE XARELTO (zah-rel-te) (rivarxaban) tablets Read this Medicatin Guide befre yu start taking XARELTO and each time yu get a refill. There may be new infrmatin. This Medicatin Guide des nt

More information

High Performance Network Quality Criteria for Designation

High Performance Network Quality Criteria for Designation Selected quality measures include: Specialty Measure Descriptin Allergy / Immunlgy Asthma Drug Mgt Vaccine Pneumnia Vaccine High Perfrmance Netwrk Quality Criteria fr Designatin AvMed has selected certain

More information

Module 6: Goal Setting

Module 6: Goal Setting Mdule 6: Gal Setting Objectives T understand the cncept f gal setting in Brief CBT T acquire skills t set feasible and apprpriate gals in Brief CBT What is gal setting, and why is it imprtant t set gals

More information

Section J. Health Conditions

Section J. Health Conditions Sectin J Health Cnditins Objectives 1 State the intent f Sectin J Health Cnditins. Identify health cnditins assessed in Sectin J that affect a resident s functinal status and quality f life. Describe hw

More information

Continuous Nerve Blocks at Home

Continuous Nerve Blocks at Home What is a peripheral nerve blck? Making a difference in the lives f children, yuth and families Cntinuus Nerve Blcks at Hme This nerve blck is a way t treat and prevent pain after surgery. Yur child s

More information

Solid Organ Transplant Benefits to Change for Texas Medicaid

Solid Organ Transplant Benefits to Change for Texas Medicaid Slid Organ Transplant Benefits t Change fr Texas Medicaid Infrmatin psted February 13, 2015 Nte: All new and updated prcedure cdes and their assciated reimbursement rates are prpsed benefits pending a

More information

Drug Therapy Guidelines

Drug Therapy Guidelines Drug Therapy Guidelines Orencia (abatacept) Applicable Medical Benefit x Effective: 2/21/18 Pharmacy- Frmulary 1 x Next Review: 12/18 Pharmacy- Frmulary 2 x Date f Origin: 11/28/06 Pharmacy- Frmulary 3/Exclusive

More information

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP

Continuous Positive Airway Pressure (CPAP) and Respiratory Assist Devices (RADs) including Bi-Level PAP Cntinuus Psitive Airway Pressure (CPAP) and Respiratry Assist Devices (RADs), Including Bi-Level PAP Benefit Criteria t Change fr Texas Medicaid Effective March 1, 2017 Overview f Benefit Changes Benefit

More information

For our protection, we require verification that you have received this notice. Therefore, please sign below.

For our protection, we require verification that you have received this notice. Therefore, please sign below. PATIENT INFORMATION Dear Patient: Sleep prblems are extremely cmmn. Public health and safety are threatened by the increasing prevalence f bstructive sleep apnea, which nw afflicts at least 25 millin adults

More information

CARE TRANSITIONS COACHES ALZHEIMER S TRAINING FACILITATOR GUIDE

CARE TRANSITIONS COACHES ALZHEIMER S TRAINING FACILITATOR GUIDE Care Transitins Prgram t Imprve Outcmes fr Peple with Alzheimer s Disease and Related Dementias CARE TRANSITIONS COACHES ALZHEIMER S TRAINING FACILITATOR GUIDE This publicatin has been created by Alzheimer

More information

Suicidal thoughts or actions:

Suicidal thoughts or actions: MEDICATION GUIDE Venlafaxine (VEN la fax een) Hydrchlride Extended-release Capsules USP Read the Medicatin Guide that cmes with venlafaxine hydrchlride extended-release capsulesbefre yu start taking them

More information

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION

CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION CONSENT FOR KYBELLA INJECTABLE FAT REDUCTION INSTRUCTIONS This is an infrmed cnsent dcument which has been prepared t help yur Dctr infrm yu cncerning fat reductin with an injectable medicatin, its risks,

More information

New Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml)

New Zealand Consumer Medicine Information. Tramadol hydrochloride immediate release capsules (50 mg) and solution for injection (50 mg/ml, 100 mg/2ml) New Zealand Cnsumer Medicine Infrmatin TRAMAL Tramadl hydrchlride immediate release capsules (50 mg) and slutin fr injectin (50 mg/ml, 100 mg/2ml) What is in this leaflet Please read this leaflet carefully

More information

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion

MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injection for intravenous infusion MEDICATION GUIDE LEMTRADA (lem-tra-da) (alemtuzumab) Injectin fr intravenus infusin Read this Medicatin Guide befre yu start receiving LEMTRADA and befre yu begin each treatment curse. There may be new

More information

NFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health

NFS284 Lecture 3. How much of a nutrient is required to maintain health? Types and amounts of foods to maintain health NFS284 Lecture 3 Chapter 2: Nutritin: Guidelines: Applying the Science f Nutritin 2.1 Nutritin Recmmendatin fr the Canadian Diet Nutrient-based apprach Hw much f a nutrient is required t maintain health?

More information

Formulary and Prescribing Guidelines

Formulary and Prescribing Guidelines SECTION 7: MANAGEMENT OF DEMENTIA Frmulary and Prescribing Guidelines 7.1 Apprved drugs fr use in cgnitive impairment f Alzheimer s disease Drug 3 Frmulatin 3 Dse 3 Licensed 4 Dnepezil Tablets 5 mg, 10

More information

Guidelines for the Admission of Children and Young People with an Eating Disorder

Guidelines for the Admission of Children and Young People with an Eating Disorder Guidelines fr the Admissin f Children and Yung Peple with an Eating Disrder This dcument is designed t be used by clinicians lcated in hspitals f wards withut specialist eating disrder facilities, t guide

More information

ANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS. Introduction to Fighting Fear by Facing Fear. Making a Fears and Worries List

ANXIETY SYMPTOMS INTERVENTION SESSION HANDOUTS. Introduction to Fighting Fear by Facing Fear. Making a Fears and Worries List SESSION ANXIETY SYMPTOMS INTERVENTION 5 SESSION HANDOUTS Handut 5.1: Handut 5.2: Handut 5.3: Handut 5.4: Handut 5.5: Handut 5.6: When Yu Face Yur Fears STOP! Intrductin t Fighting Fear by Facing Fear The

More information

New Patient Registration and Medical History. Address City State Zip code

New Patient Registration and Medical History. Address City State Zip code Wexfrd Allergy, Asthma & Immunlgy, LLC Phne (724)719 2441 / Fax (724)719 2451 100 Bradfrd Rad, Suite 410, Wexfrd, PA 15090 www.wexfrdallergy.cm New Patient Registratin and Medical Histry Name Tday s date

More information

Patient Information Packet Date:

Patient Information Packet Date: Patient Infrmatin Packet Date: We knw paperwrk is nt fun, but thank yu s much fr taking the time! Last Name: First Name: MI Address: Phne: City State: Zip Cde: Mbile: D.O.B: / / Scial Security: / / Email:

More information

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain

Pennsylvania Guidelines on the Use of Opioids to Treat Chronic Noncancer Pain Pennsylvania Guidelines n the Use f Opiids t Treat Chrnic Nncancer Pain Chrnic pain is a majr health prblem in the United States, ccurring with a pintprevalence f abut ne-third f the US ppulatin.(1) Mre

More information

APPENDIX A Certification of Advanced Disease:

APPENDIX A Certification of Advanced Disease: APPENDIX A Certificatin f Advanced Disease: Name: DOB: Member ID: Name f Palliative Care Prgram: A. General Criteria: Check each f the fllwing that apply (All needed fr eligibility). Patient wh is likely

More information

Diabetes: HbA1c Poor Control (NQF 0059)

Diabetes: HbA1c Poor Control (NQF 0059) Diabetes: HbA1c Pr Cntrl (NQF 0059) EMeasure Name Diabetes: HbA1c Pr Cntrl EMeasure Id Pending Versin Number 1 Set Id Pending Available Date N infrmatin Measurement January 1, 20xx thrugh Perid December

More information

Use of sacubitril valsartan for the treatment of symptomatic chronic heart failure with reduced ejection fraction. Shared Care Protocol

Use of sacubitril valsartan for the treatment of symptomatic chronic heart failure with reduced ejection fraction. Shared Care Protocol Oxfrdshire Clinical Cmmissining Grup Use f sacubitril valsartan fr the treatment f symptmatic chrnic heart failure with reduced ejectin fractin. Shared Care Prtcl This prtcl prvides prescribing and mnitring

More information

Colonoscopy MoviPrep Split-dose Prep Guide

Colonoscopy MoviPrep Split-dose Prep Guide Yu have been scheduled fr a Clnscpy MviPrep Split-dse Prep. Plan ahead t help reduce yur stress. Use these step-by-step instructins fr a successful prep s that yur dctr can clearly view yur cln. If yu

More information

Top 10 Causes of Disability

Top 10 Causes of Disability Tp 10 Causes f Disability Disability can happen t anyne, f any age. Thugh sme may be the result f accidents r injuries that are unavidable, many disabilities are the result f diseases and health cnditins

More information

4th$YEAR$Professional$Pharmacy$ Placement$Semester$1:$DRUG$LIST$2013$$

4th$YEAR$Professional$Pharmacy$ Placement$Semester$1:$DRUG$LIST$2013$$ 4th$YEAR$Prfessinal$Pharmacy$ Placement$Semester$1:$RUG$LIST$2013$$ Guide:Majrityfthedruglistremainsthesameeachyear,withusuallynlynertwdrugsbeing different.itisimprtanttknwtheindicatin,dse,adverseeffects,mdeftheactin(briefly),

More information

The principles of evidence-based medicine

The principles of evidence-based medicine The principles f evidence-based medicine By the end f this mdule yu shuld be able t: Describe what evidence based medicine is Knw where t find quality evidenced based medicine n the internet Be able t

More information

New Patient Information Sheet PLEASE COMPLETE THIS ENTIRE FORM. Date of Appointment: / /

New Patient Information Sheet PLEASE COMPLETE THIS ENTIRE FORM. Date of Appointment: / / New Patient Infrmatin Sheet PLEASE COMPLETE THIS ENTIRE FORM The frm may seem lengthy but it is very imprtant t help us understand yur pain cmplaints. This will help us prvide yu with the highest level

More information

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place

454-8 (Insert) MEDICATION GUIDE ZUBSOLV (Zub-solve) (buprenorphine and naloxone) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place MEDICATION GUIDE ZUBSOLV (Zub-slve) (buprenrphine and nalxne) Sublingual Tablet (CIII) IMPORTANT: Keep ZUBSOLV in a secure place away frm children. Accidental use by a child is a medical emergency and

More information

Post Distribution Monitoring Report

Post Distribution Monitoring Report Pst Distributin Mnitring Reprt Hygiene Kit funded by IMC Backgrund Infrmatin Lcatin: Zaatari Camp (All districts) Dates f data cllectin: 1-2 f Octber, 2014 Objective: t understand t what extent the distributin

More information

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher:

Year 10 Food Technology. Assessment Task 1: Foods for Special Needs. Name: Teacher: Year 10 Fd Technlgy Assessment Task 1: Fds fr Special Needs Name: Teacher: Due Date: Term 2, Week 1 Type f Task: Design Task Planning Fd Requirements Cllectin f Assessment: Submit in Class Assessment Plicy:

More information

2017 Optum, Inc. All rights reserved BH1124_112017

2017 Optum, Inc. All rights reserved BH1124_112017 1) What are the benefits t clients f encuraging the use f MAT? Withut MAT, 90% f individuals with Opiid Use Disrder (OUD) will relapse within ne year. With MAT, the relapse rate fr thse with OUD decreases

More information